HOME >> BIOLOGY >> NEWS
Biological and chemical agents in terrorism examined at AAN Annual Meeting

HONOLULU, HI (March 31, 2003) - The neurological effects of bioterrorism and the history of biological warfare will be examined at the American Academy of Neurology 55th Annual Meeting taking place this week in Honolulu.

On Tuesday, April 1, "Biological Toxins in War and Terrorism - An Historical Overview" will be presented by Shrikant Mishra, MD, Department of Neurology, Keck School of Medicine, University of Southern California. Mishra will present the historical perspective of biological toxins used in warfare and global terrorism, from ancient to contemporary times. He will focus on such biological toxins as anthrax, smallpox, and botulinum toxin, their use in war and as terrorist weapons of mass destruction.

"The recent insurgence of national and international terrorism is a potential threat to the world as a whole," says Mishra. "Lessons learned from the past will be a guiding force for the future. Early recognition and elimination of these sources, and prompt treatment of exposure to biological toxins is essential for saving humanity."

A seminar on "Bioterrorism and Neurology" on Thursday, April 3 will focus on developing bioterrorism response plans for local hospitals and clinics, which would be expected to manage neurological complications of botulism, smallpox, anthrax and nerve gases. Faculty members for this program have expertise in both the clinical and basic science aspects of bioterrorism. Each of them has had experience as "preparedness" educators in their own practice settings: a U.S. Army hospital, a Veterans Affairs Medical Center, and an Indian Health Service Medical Center. This program is designed to prepare neurologists to be better educators on the neurological issues related to bioterrorism. Participants will learn the emergency medical management of patients exposed to biological warfare agents and nerve gases, and also learn about current basic research aimed to develop neuroprotective agents against the weapons of
'"/>

Contact: Marilee Reu
mreu@aan.com
651-695-2789
American Academy of Neurology
31-Mar-2003


Page: 1 2

Related biology news :

1. Biological oceanographers examine regime shifts in complex marine ecosystems
2. Biological computer diagnoses cancer and produces drug in a test tube
3. Biological cause of one form of blindness identified by SLU researchers
4. Biological trick reveals key step in melatonins regulation
5. Journal of Gerontology: Biological Sciences to offer forum
6. Biological clock more influenced by temperature than light
7. Systematics at a Crossroads: Biological and Philosophical Arguments
8. Biological Challenges to Humanity: Emerging and Re-emerging Pathogens
9. Biological evidence can persuade people to change unhealthy habits
10. Biological warfare: an emerging threat in the 21st century
11. Biological clock gene in bees found to have another function

Post Your Comments:
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/13/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... method to make payments.  With this patent, NXT-ID ... its groundbreaking voice-direct payment patent application, with behavior-directed ...
(Date:7/9/2015)... Calif. , July 9, 2015 /PRNewswire/ ... leading developer of human interface solutions, today ... the industry,s first fully hardware encapsulated fingerprint ... secure authentication technology is literally off the ... and biometric matching within the fingerprint sensor ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
(Date:7/31/2015)... ... July 31, 2015 , ... Global ... and premium industry insights on the global resorcinol industry. The report highlights the ... of vivid market scenarios and analysis of primary and secondary inputs from the ...
(Date:7/30/2015)... , July 30, 2015   GenoSpace ... for the interpretation and analysis of genomic and ... Fischer has joined the company as Vice ... - http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace ... to integrate, interpret, analyze and explore complex sets ...
(Date:7/30/2015)... 30, 2015   Aratana Therapeutics, Inc . ... focused on the licensing, development and commercialization of ... that its strategic partner VetStem Biopharma, Inc. has ... of AT-016, an adipose-derived allogeneic stem cell product ... osteoarthritis pain in dogs. The double-blinded, ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
Cached News: